NOVEL VACCINE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14307729

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of an influenza antigen preparation obtainable by the following process, in the manufacture of an intradermal flu vaccine:

    (i) harvesting of virus-containing material from a culture;(ii) clarification of the harvested material to remove non-virus material;(iii) concentration of the harvested virus;(iv) a further step to separate whole virus from non-virus material;(v) splitting of the whole virus using a suitable splitting agent in a density gradient centrifugation step;(vi) filtration to remove undesired materials;wherein the steps are performed in that order but not necessarily consecutively.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLAXOSMITHKLINE BIOLOGICALS S A1330 RIXENSART

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
GARCON, NATHALIE Rixensart, BE 32 607
Slaoui, Moncef Mohamed Rixensart, BE 17 110
Van, Hoecke Christian Rixensart, BE 8 41

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation